Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for NeuroPace Inc Common Stock (NPCE).
- Disclosed ownership: 8.3%.
- Date of event: 31 Dec 2024.
MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for NeuroPace Inc Common Stock (NPCE)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- NeuroPace Inc Common Stock
- Symbol
- NPCE
- Shares outstanding
- 29,992,663 shares
- Disclosed Ownership
- 2,489,391 shares
- Ownership
- 8.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 Feb 2025, 12:50:49 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 8.3% ownership in NeuroPace Inc Common Stock (NPCE) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2025, 12:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 8.3% | 2,489,391 | 0 | 2,486,031 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 8.2% | 2,455,896 | 0 | 2,455,896 | Christopher O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |